Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
CorrectionErratum

Clarification: “Roles of micro-RNA-29a in the Antifibrotic Effect of Farnesoid X Receptor on Hepatic Stellate Cells”

Molecular Pharmacology August 2012, 82 (2) 360; DOI: https://doi.org/10.1124/mol.82.2.360
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

See original article:

  • Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells - July 01, 2011

In the above article [Li J, Kuruba R, Gao X, Gandhi CR, Xi W and Li S (2011) Mol Pharmacol 80:191–200], the authors reported that FXR may play a role in the regulation of miR-29a gene in hepatic stellate cells. It should be noted that the putative FXRE that they identified is 1.9 kb downstream of miR-29a gene. It is likely that the cloned sequence serves as an enhancer rather than promoter, because it has been demonstrated that miR-29a is located in exon 4 of one uncharacterized gene [expressed sequence tag AI768447; Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, and Fernandez-Zapico ME (2010) Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-κB. J Cell Biochem 110:1155–1164] and shares the same promoter with this gene. The sequence that they identified is located downstream of miR-29a but in the intron area of that uncharacterized gene 9 (see figure below). Therefore, it is more appropriate to name the pGL3-miR-29a construct “miR-29a enhancer-luciferase reporter.” These clarifications, however, do not change the authors' conclusion on a role of FXR in the regulation of miR-29a in hepatic stellate cells.

The authors apologize for any confusion or inconvenience this may have caused.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.
  • Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 82 (2)
Molecular Pharmacology
Vol. 82, Issue 2
1 Aug 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clarification: “Roles of micro-RNA-29a in the Antifibrotic Effect of Farnesoid X Receptor on Hepatic Stellate Cells”
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CorrectionErratum

Clarification: “Roles of micro-RNA-29a in the Antifibrotic Effect of Farnesoid X Receptor on Hepatic Stellate Cells”

Molecular Pharmacology August 1, 2012, 82 (2) 360; DOI: https://doi.org/10.1124/mol.82.2.360

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CorrectionErratum

Clarification: “Roles of micro-RNA-29a in the Antifibrotic Effect of Farnesoid X Receptor on Hepatic Stellate Cells”

Molecular Pharmacology August 1, 2012, 82 (2) 360; DOI: https://doi.org/10.1124/mol.82.2.360
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction to “Sulforaphane Suppresses Polycomb Group Protein Level via a Proteasome-Dependent Mechanism in Skin Cancer Cells”
  • Correction to “A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells”
  • Correction to “The Common LncRNAs of Neuroinflammation-Related Diseases”
Show more Erratum

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics